{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:21Z","timestamp":1786112781734,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      To compare the perioperative outcomes, efficacy, and safety of modified transurethral thulium laser enucleation-resection (ThuLERP) versus standard anatomic thulium laser enucleation (ThuLEP) for large-volume benign prostatic hyperplasia (BPH) (&gt; 80\u2009ml), with a primary focus on early urinary continence recovery. We retrospectively analyzed 215 patients with large-volume BPH treated between January 2021 and December 2024. Patients were segregated into the ThuLERP group (n\u2005=\u2005110), receiving anatomical enucleation of the middle and lateral lobes combined with vaporization cutting at the prostatic apex and anterior commissure, or the ThuLEP group (n\u2005=\u2005105), undergoing traditional 3-lobe anatomical enucleation. Baseline characteristics, including prostate volume (102.5\u2005\u00b1\u200521.3\u2009ml vs 104.1\u2005\u00b1\u200522.5\u2009ml), were comparable between groups. Primary outcomes assessed continence at 1 week, 1 month, and 3 months; secondary outcomes evaluated perioperative metrics and functional recovery at 6 months. All procedures were successful. The ThuLERP group demonstrated significantly shorter total operation time (65.2\u2005\u00b1\u200518.5 minutes vs 79.4\u2005\u00b1\u200520.1 minute,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.01) and enucleation time (48.1\u2005\u00b1\u200515.3 minutes vs 62.5\u2005\u00b1\u200517.8 minutes,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.01) compared to ThuLEP. Safety outcomes favored ThuLERP, showing a lower incidence of postoperative hematuria requiring intervention (6.4% vs 12.4%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05) and no reoperations for bleeding in the ThuLERP group compared to 1.9% in the ThuLEP group, although this difference was not statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u2005.05). Notably, ThuLERP resulted in superior early continence: incontinence rates were significantly lower at 1 week (8.2% vs 21.9%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.01) and 1 month (2.7% vs 9.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). By 3 months, continence rates were comparable (&gt; 98%). Both groups achieved similar significant improvements in International Prostate Symptom Score, quality of life, maximum urinary flow rate, and post-void residual at 6 months. Modified ThuLERP is as effective as standard ThuLEP regarding long-term functional outcomes for large-volume BPH. However, it offers distinct advantages by reducing operative time, improving hemostasis, and significantly accelerating the recovery of early urinary continence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048827","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:04:16Z","timestamp":1778745856000},"page":"e48827","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of modified transurethral thulium laser enucleation-resection with apical vaporization cutting versus anatomic thulium laser enucleation for large-volume (&gt; 80\u2009ml) benign prostatic hyperplasia: A retrospective comparative study"],"prefix":"10.1097","volume":"105","author":[{"given":"Wenbin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Urology, Kaifeng155 Hospital, China RongTong Medical Healthcare Group Co.Ltd., Kaifeng, China"},{"name":"Kaifeng Minimally Invasive Diagnosis and Treatment Engineering Technology Research Center for Prostate Hyperplasia, Kaifeng, China"},{"name":"Henan Province Prostate Disease Precision Diagnosis and Treatment Engineering Research Center of Traditional Chinese and Western Medicine, Kaifeng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaifeng155 Hospital, China RongTong Medical Healthcare Group Co.Ltd., Kaifeng, China"},{"name":"Kaifeng Minimally Invasive Diagnosis and Treatment Engineering Technology Research Center for Prostate Hyperplasia, Kaifeng, China"},{"name":"Henan Province Prostate Disease Precision Diagnosis and Treatment Engineering Research Center of Traditional Chinese and Western Medicine, Kaifeng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaifeng155 Hospital, China RongTong Medical Healthcare Group Co.Ltd., Kaifeng, China"},{"name":"Kaifeng Minimally Invasive Diagnosis and Treatment Engineering Technology Research Center for Prostate Hyperplasia, Kaifeng, China"},{"name":"Henan Province Prostate Disease Precision Diagnosis and Treatment Engineering Research Center of Traditional Chinese and Western Medicine, Kaifeng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaifeng155 Hospital, China RongTong Medical Healthcare Group Co.Ltd., Kaifeng, China"},{"name":"Kaifeng Minimally Invasive Diagnosis and Treatment Engineering Technology Research Center for Prostate Hyperplasia, Kaifeng, China"},{"name":"Henan Province Prostate Disease Precision Diagnosis and Treatment Engineering Research Center of Traditional Chinese and Western Medicine, Kaifeng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaifeng155 Hospital, China RongTong Medical Healthcare Group Co.Ltd., Kaifeng, China"},{"name":"Kaifeng Minimally Invasive Diagnosis and Treatment Engineering Technology Research Center for Prostate Hyperplasia, Kaifeng, China"},{"name":"Henan Province Prostate Disease Precision Diagnosis and Treatment Engineering Research Center of Traditional Chinese and Western Medicine, Kaifeng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaifeng155 Hospital, China RongTong Medical Healthcare Group Co.Ltd., Kaifeng, China"},{"name":"Kaifeng Minimally Invasive Diagnosis and Treatment Engineering Technology Research Center for Prostate Hyperplasia, Kaifeng, China"},{"name":"Henan Province Prostate Disease Precision Diagnosis and Treatment Engineering Research Center of Traditional Chinese and Western Medicine, Kaifeng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0113-3115","authenticated-orcid":false,"given":"Song","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaifeng155 Hospital, China RongTong Medical Healthcare Group Co.Ltd., Kaifeng, China"},{"name":"Kaifeng Minimally Invasive Diagnosis and Treatment Engineering Technology Research Center for Prostate Hyperplasia, Kaifeng, China"},{"name":"Henan Province Prostate Disease Precision Diagnosis and Treatment Engineering Research Center of Traditional Chinese and Western Medicine, Kaifeng, China"},{"name":"Discipline Construction Department, China RongTong Medical Healthcare Group Co.Ltd., Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"529","DOI":"10.21037\/tau.2019.10.01","article-title":"Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.","volume":"8","author":"Lokeshwar","year":"2019","journal-title":"Transl Androl Urol"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eururo.2024.04.004","article-title":"Summary paper on underactive bladder from the European Association of Urology guidelines on non-neurogenic male lower urinary tract symptoms.","volume":"86","author":"Baboudjian","year":"2024","journal-title":"Eur Urol"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","article-title":"Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention.","volume":"50","author":"Rassweiler","year":"2006","journal-title":"Eur Urol"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.eururo.2009.06.037","article-title":"Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials.","volume":"56","author":"Mamoulakis","year":"2009","journal-title":"Eur Urol"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MOU.0000000000000277","article-title":"New technologies in benign prostatic hyperplasia management.","volume":"26","author":"Roberts","year":"2016","journal-title":"Curr Opin Urol"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.eururo.2010.06.005","article-title":"Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.","volume":"58","author":"Ahyai","year":"2010","journal-title":"Eur Urol"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.eururo.2011.10.009","article-title":"Laser treatment of benign prostatic obstruction: basics and physical differences.","volume":"61","author":"Bach","year":"2012","journal-title":"Eur Urol"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/end.2005.19.25","article-title":"High-power thulium fiber laser ablation of urinary tissues at 1.94 microm.","volume":"19","author":"Fried","year":"2005","journal-title":"J Endourol"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41391-025-00996-3","article-title":"Thulium fiber laser versus holmium MOSES(TM) laser enucleation of the prostate for the treatment of benign prostatic hyperplasia: a randomized prospective clinical study.","volume":"29","author":"Elmansy","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R10-20260805","doi-asserted-by":"crossref","DOI":"10.1038\/s41391-025-01022-2","article-title":"Endoscopic simulators in benign prostatic hyperplasia surgical training: a scoping review.","author":"Siron","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nrurol.2014.23","article-title":"Laser treatment of benign prostate enlargement--which laser for which prostate?","volume":"11","author":"Rieken","year":"2014","journal-title":"Nat Rev Urol"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5534\/wjmh.2015.33.2.88","article-title":"Risk factors for transient urinary incontinence after holmium laser enucleation of the prostate.","volume":"33","author":"Nam","year":"2015","journal-title":"World J Mens Health"},{"key":"R13-20260805","article-title":"Machine learning models to predict postoperative incontinence after endoscopic enucleation of the prostate for benign prostatic hyperplasia: an EAU-Endourology study.","author":"Fong","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.3390\/cancers17183039","article-title":"Carbon-Ion radiotherapy for prostate cancer in patients with a history of surgery for benign prostatic hyperplasia.","volume":"17","author":"Okato","year":"2025","journal-title":"Cancers"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/s40001-025-03052-x","article-title":"The use of a novel complication reporting system: the comprehensive complication index in thulium laser enucleation of the prostate.","volume":"30","author":"Haifeng","year":"2025","journal-title":"Eur J Med Res"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.juro.2011.07.073","article-title":"Thulium:YAG vapoenucleation in large volume prostates.","volume":"186","author":"Bach","year":"2011","journal-title":"J Urol"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"1305006","DOI":"10.3389\/fsurg.2024.1305006","article-title":"Pretreatment of the urethral mucosa at the tip of the prostate: a retrospective review in preventing stress urinary incontinence after thulium laser enucleation of the prostate.","volume":"11","author":"Liao","year":"2024","journal-title":"Front Surg"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1089\/end.2010.0300","article-title":"Evolving transurethral resection of the prostate: enucleation-resection of the prostate.","volume":"24","author":"Galanakis","year":"2010","journal-title":"J Endourol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:02:52Z","timestamp":1785945772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":18,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048827","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2025-11-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}